These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 549007)
21. Serum alkaline phosphatase in azotemic and hemodialysis osteodystrophy: a study of isoenzyme patterns, their correlation with bone histology, and their changes in response to treatment with 1alphaOHD3 and 1,25(OH)2D3. Pierides AM; Skillen AW; Ellis HA J Lab Clin Med; 1979 Jun; 93(6):899-909. PubMed ID: 438610 [TBL] [Abstract][Full Text] [Related]
22. Osteodystrophy of dialysed patients treated with vitamin D. Verberckmoes R; Bouillon R; Krempien B Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246 [No Abstract] [Full Text] [Related]
23. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT. Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182 [No Abstract] [Full Text] [Related]
25. [Pharmacological suppression of hyperparathyroidism in patients treated by periodical hemodialysis. Histological, hormonal, biochemical and radiological study]. Brancaccio D; Faccini JM; Graziani G; Banfi G; Pedoja G; Watson L Minerva Nefrol; 1976; 23(2):149-53. PubMed ID: 1087389 [No Abstract] [Full Text] [Related]
26. Human calcitonin in the treatment of renal osteodystrophy. Farrington K; Varghese Z; Moorhead JF J Lab Clin Med; 1980 Aug; 96(2):299-306. PubMed ID: 7400664 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of renal osteodystrophy]. Duursma SA; Dorhout Mees EJ Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388 [No Abstract] [Full Text] [Related]
28. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy. Muirhead N; Catto GR; Edward N; Fraser RA; O'Riordan JL; Papapoulos SE; Adami S Proc Eur Dial Transplant Assoc; 1980; 17():543-7. PubMed ID: 6972529 [TBL] [Abstract][Full Text] [Related]
29. Renal osteodystrophy in course of periodic dialysis for chronic uremia. Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557 [No Abstract] [Full Text] [Related]
30. Fluoride and dialysis osteodystrophy: results of a double-blind study. Oreopoulos DG; Taves DR; Rabinovich S; Meema HE; Murray T; Fenton SS; deVeber GA Trans Am Soc Artif Intern Organs; 1974; 20A():203-8. PubMed ID: 4615422 [No Abstract] [Full Text] [Related]
31. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy. Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961 [TBL] [Abstract][Full Text] [Related]
32. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis]. Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690 [No Abstract] [Full Text] [Related]
33. Renal osteodystrophy and its treatment. Duursma SA; Mees EJ Neth J Med; 1973; 16(2):101-7. PubMed ID: 4705764 [No Abstract] [Full Text] [Related]